Jonathan Chong practises in all areas of intellectual property law, with a focus on patent and trade-mark litigation.
Dr. Chong’s graduate research involved the synthesis and study of porous metal-organic materials. He worked at the National Research Council of Canada and developed green chemical processes and materials derived from renewable resources. His research has been published in leading scientific journals.
Prior to joining our Montréal office, Dr. Chong articled and summered with a leading international law firm specializing in intellectual property.
Ph.D., Chemistry, University of British Columbia, 2009
B.Sc.(Hons.), Biochemistry and Chemistry, University of British Columbia, 2002
B.C.L./LL.B., McGill University, 2015
Memberships and activities
- Canadian Bar Association
- Intellectual Property Institute of Canada
- Young Bar of Montreal
On April 27 the Supreme Court dismissed Apotex Inc.’s (Apotex) application for leave to appeal the Federal Court of Appeal.
May 04, 2017
The Federal Court dismissed Bristol-Myers Squibb’s prohibition application, finding that one of the patents had an overarching promise and lacked utility, and the other patent was “obvious to try.” .
March 29, 2017